📢 Join us for the Friday Global Roundtable by Fortis Institute of Blood Disorders! 🗓️ 12 Sept, 5:30 PM IST 🎙️ Prof. Joaquín Martínez López 💡 Host: Dr. Shrinidhi Nathany Topic: In-house Rapid NGS for Myeloid Diseases #Hematology #NGS #FortisHealthcare RahulDoc

zoom.us/j/93418518465?…

Precision hematology redefined Nikhil M Kumar thankful to Shrinidhi Nathany making India proud Fortis Healthcare Agilus Diagnostics Dr. Neha Panda

Thanks Shrinidhi Nathany Fortis Healthcare Agilus Diagnostics centre of excellence for lymphoma at FMRI

When learning get new dimensions- intellect and introspect Super excited to contribute to book chapter on Infection prevention in Cancer and therapy- need and deed of an hour !! Prevention is Care and better than cure !!! Swati Bhayana - think Tank partner RahulDoc

Story of one of our patients is that of resilience, of evolving science, and of hope that keeps expanding with every breakthrough! In the world of myeloma today, hope is not a cliché—it is a clinical reality.

✨ Honored to receive the Oncomine Clinical Research Grant 2024 at the Oncomine Scientific Gala in Bordeaux 🇫🇷. Grateful to Dr. Rahul Bhargava for his inspiring leadership and to the Fortis Healthcare leadership for always fostering innovation. And nothing more perfect than

VICTORY AND HOPE IN INDIA Publication of the 1st decade-long paper on HSCT for 100 pediatric Sickle Cell Disease -OS -86.9%(n=92) Kudos to entire team & each patient for helping us work on outcomes - 1 sickling at a time, 1 patient at a time, 1 transplant at a time!

Vikram Mathews Pankaj Malhotra Prantar Chakrabarti 3.0

Francesco Maura Journal of Clinical Oncology Memorial Sloan Kettering Cancer Center Università degli Studi di Milano MD Anderson Cancer Center Moffitt Cancer Center Sylvester Comprehensive Cancer Center NYU Langone Health Wellcome Sanger Institute Mayo Clinic Our early data show enrichment of RAS/RAF/MAPK pathway alterations (~44%), DNA damage response (~18%), NF-κB signaling (~17%), and cell-cycle regulation (~13%), with occasional mismatch repair (Lynch)related variants trends reflecting unique features in our cohort n=68 in NDMM

Vincent Rajkumar Vikram Mathews Pankaj Malhotra Nikhil Kumar Shrinidhi Nathany (all her work ) Shaji Kumar Rahul Banerjee, MD, FACP Robert Z. Orlowski this on selected cells

Microhaplotype-Based Chimerism: The Future of Post-Transplant Monitoring Traditional chimerism uses STRs — reliable but limited in sensitivity. NGS-based microhaplotypes change the game. Short genomic regions with multiple linked SNPs = highly individual “DNA barcodes.” They

Innovation